Fig. 4

Responses to Questions 2–4. Responses to questions Ques.2, Ques.3, and Ques.4 for intake and continuing PHA patient surveys. a The 11-point pain scale was consolidated into three ranges (low pain: 0 to 3; medium pain: 4 to 6; and high pain: 7–10). Ques.2 was used for the intake PHA, while the outcome Ques.3 was used for all the cPHA. The number of patients that have completed the respective surveys are shown at the top of the figure as “Actual #”. The possible number who could have completed 1 or more cPHAs is shown at the top of the figure as “Possible #”. The nominal times between the iPHA and subsequent cPHAs are shown below each column. b The 11-point coping scale for Ques.4 was consolidated into three ranges (high coping: 0 to 3; medium coping: 4 to 6; and low coping: 7–10). The number of patients that have completed the respective surveys are shown at the top of the figure as “Actual #”. The possible number who could have completed one or more cPHAs is shown at the top of the figure as “Possible #”. The nominal times between the iPHA and subsequent cPHAs are shown below each column